FDA.reportPublic FDA data

INSULIN GLARGINE

Substance profile for UNII 2ZM8CX04RZ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for INSULIN GLARGINE
Structure render from PubChem CID 118984454

Substance Identity#

UNII
2ZM8CX04RZ
Preferred term
INSULIN GLARGINE
Registry number
160337-95-1
Ingredient type
INGREDIENT SUBSTANCE
Chemical structure for INSULIN GLARGINE
Structure render from PubChem CID 118984454

Chemical And Database Identifiers#

RxCUI
274783
PubChem
118984454
NCIt
C47564
INN ID
7548

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound118984454https://pubchem.ncbi.nlm.nih.gov/compound/118984454
RxNorm274783https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=274783
NCI ThesaurusC47564https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47564
FDA Substance Registration System2ZM8CX04RZhttps://precision.fda.gov/uniisearch/srs/unii/2ZM8CX04RZ

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
insulin glargineACTIVE MOIETY2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
insulin glargineACTIVE INGREDIENT2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
insulin glargineACTIVE INGREDIENT2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20001
insulin glargineACTIVE MOIETY2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20001
INSULIN GLARGINEACTIVE INGREDIENT2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
INSULIN GLARGINEACTIVE MOIETY2ZM8CX04RZThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
insulin glargineACTIVE INGREDIENT2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]22
insulin glargineACTIVE MOIETY2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]22
insulin glargineACTIVE INGREDIENT2ZM8CX04RZTOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]7
insulin glargineACTIVE MOIETY2ZM8CX04RZTOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]7
insulin glargineACTIVE INGREDIENT2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
INSULIN GLARGINEACTIVE MOIETY2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
insulin glargineACTIVE INGREDIENT2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
INSULIN GLARGINEACTIVE MOIETY2ZM8CX04RZLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1